ES8402845A1 - "procedimiento para la preparacion de 6b,7b-metilen-17x-pregn-4-en-21,17-carbolactonas" - Google Patents

"procedimiento para la preparacion de 6b,7b-metilen-17x-pregn-4-en-21,17-carbolactonas"

Info

Publication number
ES8402845A1
ES8402845A1 ES523126A ES523126A ES8402845A1 ES 8402845 A1 ES8402845 A1 ES 8402845A1 ES 523126 A ES523126 A ES 523126A ES 523126 A ES523126 A ES 523126A ES 8402845 A1 ES8402845 A1 ES 8402845A1
Authority
ES
Spain
Prior art keywords
beta
methylene
carbolactones
pregn
ene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES523126A
Other languages
English (en)
Spanish (es)
Other versions
ES523126A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES523126A0 publication Critical patent/ES523126A0/es
Publication of ES8402845A1 publication Critical patent/ES8402845A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES523126A 1982-06-09 1983-06-09 "procedimiento para la preparacion de 6b,7b-metilen-17x-pregn-4-en-21,17-carbolactonas" Expired ES8402845A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823222265 DE3222265A1 (de) 1982-06-09 1982-06-09 6ss.7ss-methylen-17(alpha)-pregn-4-en-21.17-carbolactone, verfahren zu ihrer herstellung und verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES523126A0 ES523126A0 (es) 1984-03-16
ES8402845A1 true ES8402845A1 (es) 1984-03-16

Family

ID=6166010

Family Applications (1)

Application Number Title Priority Date Filing Date
ES523126A Expired ES8402845A1 (es) 1982-06-09 1983-06-09 "procedimiento para la preparacion de 6b,7b-metilen-17x-pregn-4-en-21,17-carbolactonas"

Country Status (6)

Country Link
US (1) US4464364A (enExample)
EP (1) EP0096358B1 (enExample)
JP (1) JPS595200A (enExample)
AT (1) ATE22298T1 (enExample)
DE (2) DE3222265A1 (enExample)
ES (1) ES8402845A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3414508A1 (de) * 1984-04-13 1985-10-24 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrfach tritiierte steroid-20.17-spirolactone und ihre verwendung als tracersubstanzen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL166267C (nl) * 1968-03-22 1981-07-15 Merck & Co Inc Werkwijze ter bereiding van farmaceutische preparaten, de onder toepassing daarvan verkregen gevormde voort- brengselen, alsmede werkwijze ter bereiding van 6,7-methyleen-20-spirox-4-en-3-onderivaten met aldoste- ron remmende werking.
DE2922500A1 (de) * 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta

Also Published As

Publication number Publication date
DE3366233D1 (en) 1986-10-23
EP0096358A1 (en) 1983-12-21
ATE22298T1 (de) 1986-10-15
JPS595200A (ja) 1984-01-12
ES523126A0 (es) 1984-03-16
US4464364A (en) 1984-08-07
EP0096358B1 (en) 1986-09-17
JPH0378400B2 (enExample) 1991-12-13
DE3222265A1 (de) 1983-12-15

Similar Documents

Publication Publication Date Title
EP0219876A3 (en) Antihypertensive agents comprising 2-alkynyladenosines as active ingredients
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
MY102473A (en) Purine derivates and their pharmaceutical use
JO1502B1 (en) New pharmacy vehicles
EP0034473A3 (en) Substituted imidazoles, their preparation, pharmaceutical compositions containing the same and their use in therapy
EP0178189A3 (en) Pyridazinone derivatives, their preparation and use
EP0177940A3 (en) Hydrazine derivatives and their use
ES8702427A1 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
ES8607299A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas
ATE15048T1 (de) 4''-epi erythromycin a und seine derivate brauchbar wie antibakterielle mittel.
ZA852391B (en) Substituted benzopyrans,processes for their preparation,and their use in medicaments
ZA859797B (en) Carbapenem compounds,their preparation and use
GB2048868B (en) Preparation of 2',6'-dialkyl - n - alkoxymethyl - 2 - chloroacetanilides
ES8402845A1 (es) "procedimiento para la preparacion de 6b,7b-metilen-17x-pregn-4-en-21,17-carbolactonas"
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
DE3268541D1 (en) Benzodioxane-imidazoline compounds, their preparation and use
IL70124A (en) 5,14-dihydrobenz(5,6)isoindolo(2,1-b)isoquinoline-8,13-dione,its preparation and pharmaceutical compositions containing it
GB2162182B (en) Pharmaceutical compounds and their preparation
DE3164054D1 (en) Pharmaceutically acceptable salts of 4'-(9-acridinylamino) methanesulfon-m-anisidide, their production, and pharmaceutical compositions containing such salts
ES8400384A1 (es) Procedimiento para la preparacion de derivados de carbaciclina.
JPS56122357A (en) 7*88amino*hydroxyy11phenyll2*3*4*55tetrahydroo 1hh33bezazepines* their manufacture and medicinal composition containing them
ES8703872A1 (es) Procedimiento para preparar derivados de isoquinolina.
ES8400397A1 (es) Un procedimiento para la preparacion de un nuevo peptido activo.
IE812421L (en) Peptides